CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Shares withheld for taxes President and CEO gave up 12,744 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel/Secretary gave up 2,478 shares (to pay taxes)
- 4 Shares withheld for taxes SVP,Clinical & Medical Affairs gave up 5,310 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 6,400 shares at $1.53 ($9,792)
- 4 Open-market buy Director bought 35,000 shares at $1.63 ($57,050)
Page 4 of 36 · 720 filings